000 | 01045 a2200289 4500 | ||
---|---|---|---|
005 | 20250515222107.0 | ||
264 | 0 | _c20100602 | |
008 | 201006s 0 0 eng d | ||
022 | _a1465-3249 | ||
024 | 7 |
_a10.1080/0032472031000141278 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRobinowitz, M | |
245 | 0 | 0 |
_aFDA's new regulatory paradigms for in vitro diagnostic devices. _h[electronic resource] |
260 |
_bCytotherapy _c1999 |
||
300 |
_a353-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aDevice Approval _xlegislation & jurisprudence |
650 | 0 | 4 |
_aEquipment and Supplies _xstandards |
650 | 0 | 4 | _aGovernment Regulation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aReagent Kits, Diagnostic _xstandards |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 |
_aUnited States Food and Drug Administration _xorganization & administration |
700 | 1 | _aGutman, S I | |
773 | 0 |
_tCytotherapy _gvol. 1 _gno. 4 _gp. 353-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/0032472031000141278 _zAvailable from publisher's website |
999 |
_c19783407 _d19783407 |